ATE369132T1 - Verfahren zur herstellung von losartan kaliumsalz mit verbesserten fliesseigenschaften - Google Patents

Verfahren zur herstellung von losartan kaliumsalz mit verbesserten fliesseigenschaften

Info

Publication number
ATE369132T1
ATE369132T1 AT03776442T AT03776442T ATE369132T1 AT E369132 T1 ATE369132 T1 AT E369132T1 AT 03776442 T AT03776442 T AT 03776442T AT 03776442 T AT03776442 T AT 03776442T AT E369132 T1 ATE369132 T1 AT E369132T1
Authority
AT
Austria
Prior art keywords
potassium salt
flow properties
losartan potassium
improved flow
producing
Prior art date
Application number
AT03776442T
Other languages
English (en)
Inventor
Igor Lifshitz
Ilan Kor
Shalom Shabat
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Application granted granted Critical
Publication of ATE369132T1 publication Critical patent/ATE369132T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
AT03776442T 2002-10-17 2003-10-17 Verfahren zur herstellung von losartan kaliumsalz mit verbesserten fliesseigenschaften ATE369132T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US41945002P 2002-10-17 2002-10-17
US42607202P 2002-11-12 2002-11-12
US42646102P 2002-11-14 2002-11-14
US43145002P 2002-12-04 2002-12-04
US43180902P 2002-12-09 2002-12-09

Publications (1)

Publication Number Publication Date
ATE369132T1 true ATE369132T1 (de) 2007-08-15

Family

ID=32111134

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03776442T ATE369132T1 (de) 2002-10-17 2003-10-17 Verfahren zur herstellung von losartan kaliumsalz mit verbesserten fliesseigenschaften

Country Status (7)

Country Link
US (2) US20040171843A1 (de)
EP (1) EP1471908B1 (de)
AT (1) ATE369132T1 (de)
AU (1) AU2003284262A1 (de)
DE (1) DE60315417T2 (de)
ES (1) ES2290518T3 (de)
WO (1) WO2004035049A1 (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2173433T3 (es) * 1996-10-29 2002-10-16 Merck & Co Inc Procedimiento para la cristalizacion de losartan.
ES2234451T1 (es) * 2001-11-14 2005-07-01 Teva Pharmaceutical Industries Ltd. Formas cristalinas y amorfas de losartan potasio y procedimiento para su preparacion.

Also Published As

Publication number Publication date
AU2003284262A1 (en) 2004-05-04
EP1471908A1 (de) 2004-11-03
DE60315417D1 (de) 2007-09-20
DE60315417T2 (de) 2008-04-30
EP1471908B1 (de) 2007-08-08
US20060241161A1 (en) 2006-10-26
US20040171843A1 (en) 2004-09-02
WO2004035049A1 (en) 2004-04-29
ES2290518T3 (es) 2008-02-16
AU2003284262A8 (en) 2004-05-04

Similar Documents

Publication Publication Date Title
DE502004009142D1 (de) Verfahren zur herstellung substituierter 3-aryl-butyl-aminverbindungen
ATE501182T1 (de) Verfahren zur herstellung eines olefinpolymerisationskatalysators
DE502006001309D1 (de) Arzneimitteldepot zur parenteralen, insbesondere intravaskulären Arzneimittelfreisetzung
DE50304622D1 (de) Verfahren zur Herstellung einer elastischen, luftdurchlässigen Verbundfolie
ATE506356T1 (de) Verfahren zur herstellung von 3-halo-4,5-dihydro- 1h-pyrazolen
ATE374767T1 (de) Dehydrophenylahistine und analoge davon sowie ein verfahren zur herstellung von dehydrophenylahistinen und analogen davon
DE60323192D1 (de) Verfahren zur Herstellung von Hydroxyalkylstärkederivaten
DE502005000428D1 (de) Verfahren zur Herstellung von 1,2-Diaminocyclohexan-Platin(II)-Komplexen
DE602005013895D1 (de) Vorrichtung zur Herstellung von Reifenbestandteilen.
DE602005001724D1 (de) Verfahren zur Herstellung von Bildaufzeichnungsmaterialien.
DE502006002680D1 (de) Verfahren zur herstellung von feinteiligem c.i. pigment red 254
ATE391115T1 (de) Verfahren zur herstellung von diketenacetalen
DE60316359D1 (de) Verfahren zur herstellung von 3,5-bis(trifluormethyl)benzylalkohol
ATE275149T1 (de) Verfahren zur herstellung von taxanderivaten
ATE464289T1 (de) Neues verfahren zur herstellung von thoc
ATE369132T1 (de) Verfahren zur herstellung von losartan kaliumsalz mit verbesserten fliesseigenschaften
DE60322356D1 (de) Verfahren zur herstellung von 2-aminoindanderivaten
ATE365709T1 (de) Verfahren zur herstellung von pyrazinverbindungen
DE502004010100D1 (de) Verfahren zur Herstellung von 9,10-Dihydro-9-oxa-10-organyl-oxyphosphaphenanthren-10-oxid oder -thion und an den Phenylgruppen substituierten Derivativen desselben
DE502004007865D1 (de) Verfahren zur herstellung bzw. bearbeitung von gasturbinenbauteilen
ATE496038T1 (de) Verfahren zur herstellung von quetiapin
DE602004005239D1 (de) Verfahren zur herstellung von tubulininhibitoren
DE60301444T2 (de) Verfahren zur Herstellung von Polyalkylphenoxyaminoalkanen
DE60302979D1 (de) Verfahren zur Herstellung von Epsilon-Caprolactone
ATA8952000A (de) Verfahren zur herstellung von 2-chlor-5-chlormethyl-1,3-thiazol

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties